Secondary hypertension
Download
1 / 44

SECONDARY HYPERTENSION - PowerPoint PPT Presentation


  • 117 Views
  • Uploaded on

SECONDARY HYPERTENSION. DEFINITION. Essential, primary, or idiopathic hypertension is defined as high BP in which secondary causes or mendelian (monogenic) forms are not present High BP – repeatedly measured BP exceeding 140/90 mmHg, i.e. a systolic BP above 140 and/or diastolic BP above 90.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' SECONDARY HYPERTENSION' - medea


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Definition
DEFINITION

  • Essential, primary, or idiopathic hypertension is defined as high BP in which secondary causes or mendelian (monogenic) forms are not present

  • High BP – repeatedly measured BP exceeding 140/90 mmHg, i.e. a systolic BP above 140 and/or diastolic BP above 90


Aetiology of hypertension
Aetiology of Hypertension

  • Primary – 90-95% of cases – also termed “essential” of “idiopathic”

  • Secondary – about 5% of cases

    • Renal or renovascular disease

    • Endocrine disease

      • Phaeochomocytoma

      • Cushings syndrome

      • Conn’s syndrome

      • Acromegaly and hypothyroidism

    • Coarctation of the aorta

    • Iatrogenic

      • Hormonal / oral contraceptive

      • NSAIDs


Aetiology of hypertension1
Aetiology of Hypertension

  • Primary – 90-95% of cases – also termed “essential” of “idiopathic”

  • Secondary – about 5% of cases

    • Renal parenchymal (2-5%)

      or renovascular disease

    • Endocrine disease

      • Phaeochomocytoma

      • Cushing syndrome

      • Conn syndrome

      • Acromegaly and hypothyroidism

    • Coarctation of the aorta

    • Iatrogenic

      • Hormonal / oral contraceptive

      • NSAIDs


Renal parenchymal disease
Renal parenchymal disease

  • Acute and chronic glomerulonephritis

  • Polycystic kidney disease

  • Diabetic nephropathy

  • Pyelonephritis

  • Obstructive uropathy

  • Neoplasms

  • Renal trauma

  • Radiation nephritis


Renal parenchymal disease1
Renal parenchymal disease

CIN – chronic interstitial nephritis; APKD – adult-onset polycystic kidney disease; MCN - minimal change nephropathy; MGN – membranous glomerulonephritis; DN – diabetic nephropathy; MPGN – membranoproliferative glomerulonephritis; FSGN – focal segmental glomerulonephritis


Candidate pathophysiologic mechanisms related to hypertension in parenchymal renal disease
Candidate pathophysiologic mechanisms related to hypertension in parenchymal renal disease


Hypertension in parenchymal renal disease major target organ manifestations
Hypertension in parenchymal renal disease: hypertension in parenchymal renal diseasemajor target organ manifestations


Hypertension in parenchymal renal disease
Hypertension in parenchymal renal disease hypertension in parenchymal renal disease


Hypertension in parenchymal renal disease conclusions
Hypertension in parenchymal renal disease: hypertension in parenchymal renal diseaseCONCLUSIONS

  • Hypertension may result from renal disease that reduces functioning nephrons;

  • Evidence shows a clear relationship between high blood pressure and end-stage renal disease;

  • BP should be controlled to 130/85 mmHg (125/75 mmHg in patients with proteinuria in excess of 1g/24 h)


Aetiology of hypertension2
Aetiology of Hypertension hypertension in parenchymal renal disease

  • Primary – 90-95% of cases – also termed “essential” of “idiopathic”

  • Secondary – about 5% of cases

    • Renal parenchymal

      or renovascular disease (0.3-3%)

    • Endocrine disease

      • Phaeochomocytoma

      • Cushings syndrome

      • Conn’s syndrome

      • Acromegaly and hypothyroidism

    • Coarctation of the aorta

    • Iatrogenic

      • Hormonal / oral contraceptive

      • NSAIDs


Renal artery stenosis ras
RENAL ARTERY STENOSIS hypertension in parenchymal renal disease(RAS)

  • Atherosclerotic RAS (>90% of cases): involves the ostium and the proximal portion of the main renal artery with plaque extending into the perirenal aorta

  • Fibromuscular dysplasia (10% of cases): typically seen in young and middle-aged females. As opposed to atherosclerotic RAS, fibromuscular dysplasia typically affects the distal two thirds of the main renal artery


Renal artery stenosis screening and diagnostic studies
RENAL ARTERY STENOSIS: hypertension in parenchymal renal diseasescreening and diagnostic studies

  • Renal duplex sonography

  • Magnetic resonance angiography

  • Renal artery arteriography

  • Captopril renography


Renal artery stenosis renal duplex sonography
RENAL ARTERY STENOSIS: hypertension in parenchymal renal diseaserenal duplex sonography

Stenoses over 60%:

  • Peak systolic velocity (PSV) >150-180 cm/sec

  • Renal-aortic ratio >3.5

    Prognostic value:

  • Resistance index (RI):

    RI=(1-EDV)/PSVx100;

    if RI>80 no benefit after revascularization


Renal artery stenosis mr angiography
RENAL ARTERY STENOSIS: hypertension in parenchymal renal diseaseMR angiography

Strong sides:

  • Provides images of the renal arteries, 3D-reconstruction, plaque characterization and hemodynamic information

  • Gadolinium (contrast agent): non-nephrotoxic

    Weak sides: high cost and limited availability


Renal artery evaluation mr angiography 3d reconstruction
RENAL ARTERY EVALUATION: hypertension in parenchymal renal diseaseMR angiography (3D-reconstruction)


Renal artery evaluation contrast angiography the gold standard
RENAL ARTERY EVALUATION: hypertension in parenchymal renal diseasecontrast angiography (the “gold” standard)

Fibromuscular dysplasia:

“string of beads” appearance

Atherosclerotic RAS with

poststenotic dilatation


What is your diagnosis
What is your diagnosis ? hypertension in parenchymal renal disease


Renal artery stenosis treatment
RENAL ARTERY STENOSIS: hypertension in parenchymal renal diseasetreatment

  • BP control

  • Antiplatelet, lipid-lowering therapy, and beta-blockers, if appropriate

  • No ACE-inhibitors in severe RAS !


Renal artery stenosis treatment1
RENAL ARTERY STENOSIS: hypertension in parenchymal renal diseasetreatment

Percutaneous or surgical revascularization, if:

● Resistant or poorly controlled hypertension and unilateral or bilateral renal artery stenosis

● Renal artery stenosis and recurrent flash pulmonary edema for which there is no readily explainable cause

● Chronic renal failure and bilateral renal artery stenosis or renal artery stenosis to asolitary functioning kidney

● Sonographic renal longitudinal length >7cm


Aetiology of hypertension3
Aetiology of Hypertension hypertension in parenchymal renal disease

  • Primary – 90-95% of cases – also termed “essential” of “idiopathic”

  • Secondary – about 5% of cases

    • Renal or renovascular disease

    • Endocrine disease

      • Phaeochomocytoma (0.1-0.6 %)

      • Cushings syndrome

      • Conn’s syndrome

      • Acromegaly and hypothyroidism

    • Coarctation of the aorta

    • Iatrogenic

      • Hormonal / oral contraceptive

      • NSAIDs


Pheochromocytoma frequently searched for but rarely found
PHEOCHROMOCYTOMA hypertension in parenchymal renal disease“frequently searched for, but rarely found”

  • About 90 % of pheochromocytomas are located within the adrenal glands;

  • 10% are bilateral;

  • 10% are malignant;

  • 10% are extra-adrenal;

  • Extra-adrenal pheochromocytomas develop in paraganglion chromaffin tissue of the sympathetic nervous system; of them, 40% are not diagnosed, 5% are multiple;

  • overall, nearly 98% of pheochromocytomas are found in the abdomen


Frequency of signs and symptoms of pheochromocytoma

PHEOCHROMOCYTOMA hypertension in parenchymal renal disease“the great mimic”

Frequency of signs and symptoms (%) of pheochromocytoma


PHEOCHROMOCYTOMA hypertension in parenchymal renal diseasediagnostic techniques

  • Biochemical tests

  • High pressure liquid chromatography:

  • Plasma catecholamines: noradrenaline, adrenaline;

  • Free plasma fractionated metanephrines: normetanephrine, metanephrine;

  • Urinary catecholamines (24h)

  • Urinary fractionated metanephrines (24h)

  • Spectrophotometry:

  • Total metanephrines (24h urine);

  • Vanillylmandelic acid(24h urine)


PHEOCHROMOCYTOMA hypertension in parenchymal renal disease

Sensitivity and specifity of biochemical tests for diagnosis of pheochromocytoma


PHEOCHROMOCYTOMA hypertension in parenchymal renal diseaseimaging techniques

  • Duplex sonography;

  • Magnetic resonance imaging (MRI);

  • Computed romography (CT);

  • 123I – meta-iodo-benzyl-guanidine scanning (123I-MIBG)


Pheochromocytoma
PHEOCHROMOCYTOMA hypertension in parenchymal renal disease

Sonography :

  • Sonographic appearances are those of a well-defined homogeneous hypoechoic mass in approximately 50 pet cent of patients.

  • However the mass may be complex or even cystic (16 pet cent) and hyperechoic to the renal parenchyma (approximately 20 pet cent).


Pheochromocytoma1
PHEOCHROMOCYTOMA hypertension in parenchymal renal disease

MRI (coronal and sagittal sections):

  • Magnetic resonance (MR) imaging is equally sensitive to CT and lends itself to in vivo tissue characterization, which is not possible with CT;

  • MR imaging is nearly 100% sensitive and around 70% specific.

  • Preferred for the localisation of extra-adrenal tumours or tumours during pregnancy, in children, or in patients with allergies to contrast


Pheochromocytoma2
PHEOCHROMOCYTOMA hypertension in parenchymal renal disease

CT:

  • accurately detects tumors larger than 1.0 cm and has a localization precision of approximately 98%, although it is only 70% specific;

  • since CT scanning and MRI have similar sensitivities (90–100%) and specificities (70–80%), MRI is the preferred procedure


Pheochromocytoma3
PHEOCHROMOCYTOMA hypertension in parenchymal renal disease

123I-MIBG scanning:

  • increased specificity (95–100%), as compared with CT or MRI;

  • provides both anatomic and functional characterization;

  • Relevant in patients with multiple, extra-adrenal, malignant (metastatic) tumors


PHEOCHROMOCYTOMA: laparoscopic removal hypertension in parenchymal renal disease

Preoperative Management (10-14 days)

  • Purpose:to prevent catecholamine induced, serious, and potentially life-threatening complications during surgery, including hypertensive crises, cardiac arrhythmias, pulmonary oedema, and cardiac ischemia;

  • BP should be reduced to below 160/90 mm Hg for at least 24h;

  • orthostatic hypotension should be present, but blood pressure in the upright position should not fall below 80/45 mm Hg;

  • there should be no more than one ventricular extrasystole every 5 min;

  • and the electrocardiogram should show no S-T segment changes and T-wave inversions for 1 week;


PHEOCHROMOCYTOMA: hypertension in parenchymal renal disease

Management

  • Phenoxybenzamine, a long acting alpha-adrenergic blocker, is the mainstay of medical treatment to control BP. A total dose of 1 mg/kg is sufficient in most patients.

  • An alpha-blocker Doxazosin in increasing doses from 1 to 16 mg once a day.

  • A beta-adrenoceptor blocker (eg,propranolol 40 mg three times daily or atenolol 25–50 mg once daily) could be included after several days of alpha-adrenergic blockade.

  • Adequate salt and fluid intake lowers the risk of orthostatic hypotension.


PHEOCHROMOCYTOMA: hypertension in parenchymal renal disease

Management

  • Should substantial rises in blood pressure still take place during surgery, these can be controlled by bolus or by continuous infusion of phentolamine, sodium nitroprusside, or a shortacting calcium antagonist (eg, nicardipine);

  • Tachyarrhythmias can be treated by infusion of a shortacting -adrenoceptor blocker (eg, esmolol).


PHEOCHROMOCYTOMA hypertension in parenchymal renal disease

Sensitivity and specifity of biochemical tests for diagnosis of pheochromocytoma


Conn s syndrome primary hyperaldosteronism
Conn’s Syndrome hypertension in parenchymal renal disease(primary hyperaldosteronism)

  • Should be considered in any hypertensive pt with muscle weakness, polydipsia, andor hypokalemia;

  • 75% - adrenal adenoma;

  • 25% - adrenal hyperplasia

  • Rarely – adrenocortical cancer


Primary hyperaldosteronism
Primary Hyperaldosteronism hypertension in parenchymal renal disease

  • Screening for hyperaldosteronism should include plasma aldosterone and plasma renin activity

    measured in morning samples

  • Plasma aldosterone:renin ratio: normally <20;

    diagnostic cut-off value >30;

  • Aldosterone excretion rate during salt loading, captopril, or spironolactone test (the captopril test may be less useful in blacks because of the high prevalence of low plasma renin activity)

  • Adrenal CT, MRI


Primary hyperaldosteronism1
Primary Hyperaldosteronism hypertension in parenchymal renal disease

Should be differentiated from

  • Secondary hyperaldosteronism in patients with renal failure, CHF, essential hypertension

  • Monogenic forms of hypertension (pseudohyperaldosteronism):

  • Liddle’s syndrome (autosomal-dominant disorder, characterized by low-renin, low-aldosterone, low-potassium volume-expanded hypertension)

  • Gordon’s syndrome (autosomal-dominant disorder, characterized by low-renin, low-aldosterone, high-potassium volume-expanded hypertension)


Primary hyperaldosteronism2
Primary Hyperaldosteronism hypertension in parenchymal renal disease

TREATMENT

1. Medical

  • Spironolactone, a competitive aldosterone antagonist

  • Amiloride, a potassium-sparing diuretic

  • Glucocorticoids (in glucocorticoid-remediable form)

    2. Surgical, if appropriate


Aetiology of hypertension4
Aetiology of Hypertension hypertension in parenchymal renal disease

  • Primary – 90-95% of cases – also termed “essential” of “idiopathic”

  • Secondary – about 5% of cases

    • Renal or renovascular disease

    • Endocrine disease

      • Phaeochomocytoma

      • Cushing’s syndrome (0.1-0.6%)

        Conn’s syndrome

      • Acromegaly and hypothyroidism

    • Coarctation of the aorta

    • Iatrogenic

      • Hormonal / oral contraceptive

      • NSAIDs


Cushing s syndrome
Cushing’s Syndrome hypertension in parenchymal renal disease

  • Hypertension occurs in about 80% of patients;

  • Urinary free cortisol

  • If 24h UFC>100 µg/ml: measure plasma ACTH


Hypothyroidism
Hypothyroidism hypertension in parenchymal renal disease

  • Both hypertension (particularly diastolic) and hypotension are common;

    Hyperthyroidism

  • Accompanied by systolic hypertension, especially in the elderly;

    Acromegaly

  • 25-50% exhibit elevated blood pressure


ad